Apellis Pharmaceuticals, Inc. (APLS)

NASDAQ: APLS · IEX Real-Time Price · USD

37.98

+0.03 (0.08%)

At close: Jul 19, 2024, 4:00 PM

37.96

-0.02 (-0.05%)

Pre-market: Jul 22, 2024, 8:52 AM EDT

Apellis Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2015
Net Income	-417.27	-528.63	-652.17	-746.35	-344.87	-304.71	Upgrade
Depreciation & Amortization	1.75	1.7	1.49	1.49	0.86	0.6	Upgrade
Share-Based Compensation	107.47	105.95	91.09	70.67	45.38	21.14	Upgrade
Other Operating Activities	-242.05	-173.76	45.86	111.07	138.15	71.83	Upgrade
Operating Cash Flow	-550.1	-594.74	-513.75	-563.13	-160.49	-211.14	Upgrade
Capital Expenditures	-0.71	-0.67	-1.52	-1.1	-5.42	-1.69	Upgrade
Change in Investments	0	0	61.42	248.72	-311.57	0	Upgrade
Investing Cash Flow	-0.71	-0.67	59.89	247.62	-316.99	-1.69	Upgrade
Share Issuance / Repurchase	68.41	461.04	405.84	398.02	392.42	112.71	Upgrade
Debt Issued / Paid	98.76	0	0	0	322.87	184.21	Upgrade
Other Financing Activities	-55.57	-66.54	-40.18	-5.79	-23.11	91.62	Upgrade
Financing Cash Flow	111.61	394.5	365.66	392.24	692.18	388.54	Upgrade
Exchange Rate Effect	-0.13	0.14	-0.49	-2.02	0.36	0	Upgrade
Net Cash Flow	-439.33	-200.78	-88.68	74.71	215.06	175.72	Upgrade
Free Cash Flow	-550.81	-595.41	-515.27	-564.23	-165.91	-212.83	Upgrade
Free Cash Flow Margin	-105.10%	-150.13%	-683.18%	-847.66%	-66.19%	-	Upgrade
Free Cash Flow Per Share	-4.48	-5.02	-4.86	-6.68	-2.21	-3.42	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).